Does VELAGLUCERASE ALFA Cause Product distribution issue? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Product distribution issue have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 1.4% of all adverse event reports for VELAGLUCERASE ALFA.
25
Reports of Product distribution issue with VELAGLUCERASE ALFA
1.4%
of all VELAGLUCERASE ALFA reports
0
Deaths
9
Hospitalizations
How Dangerous Is Product distribution issue From VELAGLUCERASE ALFA?
Of the 25 reports, 9 (36.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does VELAGLUCERASE ALFA Cause?
Inappropriate schedule of product administration (197)
Product dose omission issue (188)
Covid-19 (163)
Fatigue (136)
Death (108)
Fall (104)
Pyrexia (101)
Malaise (98)
Weight increased (89)
Headache (88)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which VELAGLUCERASE ALFA Alternatives Have Lower Product distribution issue Risk?
VELAGLUCERASE ALFA vs VELCADE
VELAGLUCERASE ALFA vs VELETRI
VELAGLUCERASE ALFA vs VELIPARIB
VELAGLUCERASE ALFA vs VEMURAFENIB
VELAGLUCERASE ALFA vs VENETOCLAX